Blocking crucial molecule could help treat multiple sclerosis, Jefferson neuroscientists say
Sunday, April 24, 2011 - 12:30
in Health & Medicine
PHILADELPHIA -- Reporting in Nature Immunology, Jefferson neuroscientists have identified a driving force behind autoimmune diseases such as multiple sclerosis (MS), and suggest that blocking this cell-signaling molecule is the first step in d...